Cervarix Gets One Up On Gardasil In Cross-Protection: HPV-31 In FDA Approval

More limited cross protection claim approved by FDA still gives GSK a selling point in its effort to dislodge Merck's Gardasil from its exclusive position in the U.S. HPV protection vaccine market.